HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miguel A Pozo Selected Research

2-methyl-5-HT

3/2005Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miguel A Pozo Research Topics

Disease

5Status Epilepticus (Complex Partial Status Epilepticus)
01/2018 - 11/2003
5Gliosis
01/2018 - 04/2015
5Seizures (Absence Seizure)
01/2018 - 11/2003
3Alzheimer Disease (Alzheimer's Disease)
11/2016 - 01/2012
2Neuroinflammatory Diseases
01/2018 - 01/2012
2Epilepsy (Aura)
01/2017 - 02/2015
1Nervous System Diseases (Neurological Disorders)
01/2018
1Temporal Lobe Epilepsy
09/2017
1Huntington Disease (Huntington's Disease)
03/2017
1Mitochondrial Diseases (Mitochondrial Disease)
03/2017
1Disease Progression
03/2017
1Dystonia (Limb Dystonia)
12/2016
1Cerebellar Diseases (Cerebellar Syndrome)
12/2016
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
12/2016
1Ataxia (Dyssynergia)
12/2016
1Muscle Weakness
12/2016
1Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
12/2016
1Brain Diseases (Brain Disorder)
11/2016
1Amyloidosis
11/2016
1Porphyrias (Porphyria)
04/2016
1Acute Intermittent Porphyria (Porphyria, Acute)
04/2016
1Hypoxia (Hypoxemia)
08/2015
1Brain Hypoxia (Cerebral Hypoxia)
08/2015
1Ischemic Stroke
08/2015
1Stroke (Strokes)
08/2015
1Tauopathies
01/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2014
1Inflammation (Inflammations)
01/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2005
1Neoplasm Metastasis (Metastasis)
11/2005
1Bradycardia
03/2005
1Neuralgia (Stump Neuralgia)
03/2004
1Migraine Disorders (Migraine)
03/2004

Drug/Important Bio-Agent (IBA)

4LithiumIBA
01/2018 - 02/2015
4Pilocarpine (Ocusert)FDA LinkGeneric
01/2018 - 02/2015
3Glial Fibrillary Acidic ProteinIBA
01/2018 - 04/2015
3fluoro-jade CIBA
01/2018 - 04/2015
3CannabinoidsIBA
03/2017 - 01/2012
3Glucose (Dextrose)FDA LinkGeneric
12/2016 - 04/2016
3Serotonin (5 Hydroxytryptamine)IBA
05/2016 - 02/2015
2MetyraponeFDA Link
01/2018 - 09/2017
2Neuroprotective AgentsIBA
01/2018 - 01/2017
2EnzymesIBA
01/2018 - 12/2016
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2017 - 03/2004
2EndocannabinoidsIBA
12/2016 - 11/2016
2Fluoxetine (Prozac)FDA LinkGeneric
05/2016 - 02/2015
2Valproic Acid (Depakote)FDA LinkGeneric
03/2004 - 11/2003
1Caspase 3 (Caspase-3)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
09/2017
1GlucocorticoidsIBA
09/2017
1Protons (Proton)IBA
03/2017
1nabiximols (Sativex)IBA
03/2017
1Antidepressive Agents (Antidepressants)IBA
01/2017
1Caspase 9IBA
01/2017
1Glutamic Acid (Glutamate)FDA Link
12/2016
1anandamide (arachidonylethanolamide)IBA
11/2016
1Heme (Haem)IBA
04/2016
1Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
04/2016
1pipoxolan (BR 18)IBA
08/2015
1fluoromisonidazoleIBA
08/2015
1DAPIIBA
04/2015
1Glycogen Synthase Kinase 3IBA
02/2014
1Glycogen Synthase (Synthase I)IBA
02/2014
1tau Proteins (tau Protein)IBA
01/2014
1Amyloid (Amyloid Fibrils)IBA
01/2012
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2012
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2005
1Cholinergic Agents (Cholinergics)IBA
11/2005
12-methyl-5-HTIBA
03/2005
14-Aminopyridine (4 Aminopyridine)FDA Link
11/2003
1Pharmaceutical PreparationsIBA
11/2003

Therapy/Procedure

1Thoracotomy
11/2005